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INTRODUCTION
Asthma is more common in women than men (Schatz and Camargo, 2003; Melgert et al., 2007) , with symptoms exacerbated during the menstrual cycle and with pregnancy (Vrieze et al., 2003; Farha et al., 2009) . These data suggest that sex steroids (e.g. estrogens) play a role in asthma. However, the mechanisms by which sex steroids influence the airway in a beneficial or detrimental fashion are still under investigation.
An important aspect of asthma pathophysiology is enhanced airway tone, which represents a balance between bronchodilation and bronchoconstriction, both of which could potentially be modulated by estrogens on a rapid timescale, thus dynamically altering airway tone. In this regard, we have previously shown that clinically-relevant concentrations of estrogens can acutely (i.e. within minutes) reduce intracellular Ca 2+ ([Ca 2+ ] i ) in airway smooth muscle (ASM) (Townsend et al., 2010) , thus rapidly reducing bronchoconstriction. However, the mechanisms by which estrogens may influence bronchodilation have not been well-studied.
Nitric oxide (NO) is a major endogenous as well as exogenous bronchodilator (Nijkamp and Folkerts, 1995; Feletou et al., 2001; Folkerts and Nijkamp, 2006) . In airways, NO may be derived from airway epithelium, (Di Maria et al., 2000; Shaul, 2002; Bove and van der Vliet, 2006) non-adrenergic/non-cholinergic innervation, (Lammers et al., 1992; Belvisi et al., 1995) and ASM (Nijkamp and Folkerts, 1995) . All three NOS isoforms (nNOS, eNOS and iNOS) are known to be expressed within the respiratory tract (Shaul, 2002; Ricciardolo et al., 2004; Bove and van der Vliet, 2006) , with airway epithelium being a major site for eNOS and iNOS, the latter especially in the asthmatic airway (Ortiz and Garvin, 2003; Jiang et al., 2009) . While NO has several mechanisms of This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on jpet.aspetjournals.org Downloaded from JPET #184416 5 action, the bronchodilatory properties of NO on ASM are of particular interest in terms of regulation of airway tone and its dysfunction in airway hyperreactivity and inflammation.
The effects of sex steroids such as estrogen or progesterone on the airway epithelium have not been well-studied (Ricciardolo et al., 2004; Bove and van der Vliet, 2006) . In vascular endothelium, estrogens, acting via estrogen receptors (ERs) induce rapid NO production (and vasodilation) by facilitating caveolar dissociation from eNOS (Hisamoto and Bender, 2005) . Whether a similar set of mechanisms is involved or whether estrogens actually produce NO in airway epithelium is not known. Estrogen receptors (ERs) are known to be present in airway epithelium (Ivanova et al., 2009) , with both cytoplasmic and nuclear localization. A previous study found levels of exhaled NO production, a marker of inflammation in asthma, to be higher during the late-follicular phase (Kharitonov et al., 1994) , but this finding likely reflect iNOS activity (the major source of exhaled NO). A single study using NCI-H441 lung adenocarcinoma epithelial cells showed that acute exposure to estradiol increases the conversion of [ (Kirsch et al., 1999) , but did not demonstrate NO production. In the present study, using acutely dissociated, normal human bronchial epithelial cells (BECs), and epithelium-intact vs. -denuded bronchial rings, from females, we tested the hypothesis that estrogen enhances rapid (likely non-genomic) NO production via eNOS activation thereby potentiating bronchodilation.
This article has not been copyedited and formatted. The final version may differ from this version. No attempts were made to determine hormonal status (pre-or post-menopausal) of the patients at the time of surgery; however ER expression was confirmed in all samples prior to further experimentation.
Airway samples were rapidly transferred to the laboratory in ice-cold Hanks Balanced Salt Solution (HBSS). The bronchial epithelium was dissected from the smooth muscle and cartilage on ice, minced, and transferred T25 flasks or 8-well Lab-Teks (Nalgene Nunc International, Rochester, NY). Explants were grown in a 95% air/ 5% CO 2 humidified incubator using Basal Epithelial Growth Medium supplemented with BPE, 2 ml; Hydrocortisone, 0.5 ml; hEGF, 0.5 ml; Epinephrine, 0.5 ml; Transferrin,0.5 ml; Insulin, 0.5 ml; Retinoic Acid, 0.5 ml; Triiodothyronine, 0.5 ml; GA-1000, 0.5 ml This article has not been copyedited and formatted. The final version may differ from this version. 
Isolation of Cellular Fractions
Human BECs were harvested and cellular fractions were prepared by separation into heavy (nuclear/Golgi), cytosolic, and membrane fractions using the FractionPREP Cell Fractionation System (BioVision Inc. Mountain View CA; manufacturer-provided protocol) as described previously for ASM (Townsend et al., 2010) .
Western Blot Analysis
Standard SDS-PAGE (Criterion Gel System; Bio-Rad, Hercules, CA; 10% gradient gels) and PVDF membrane (Bio-Rad) transfer techniques were used. Membranes were blotted for ERα (1 μg/ml (1:200 dilution) rabbit anti-ERα; Santa Cruz Biotechnology Inc. SC-542), ERβ (1 μg/ml (1:200 dilution) mouse anti-ERβ; Santa Cruz SC-53494), eNOS (1 μg/ml (1:250 dilution); mouse anti-eNOS; BD Transduction Laboratories, Franklin Lakes, NJ), p-eNOS (1 μg/ml (1:250 dilution); mouse anti-peNOS (pSer1177); BD Transduction Laboratories), iNOS (1.5mg/ml (1:650 dilution); rabbit anti-iNOS; Cell Signaling Technology #2977), AKT (1μg/ml (1:1000 dilution); rabbit anti-AKT; Cell Signaling Technology #9272), and p-AKT (1μg/ml (1:1000 dilution); rabbit anti-p-AKT; Cell Signaling Technology #9271). GAPDH (1μg/ml
(1:1000 dilution); rabbit anti-GAPDH; Cell Signaling Technology #2118) was used for and quantified using densitometry.
Immunofluorescence Microscopy
ER expression in BECs was verified using immunofluorescence as described for other proteins (Townsend et al., 2010 
Real-time NO imaging
BECs grown in 8-well Labtek chambers were loaded with the NO-sensitive fluorescent dye 4,5 diaminofluorescein diacetate (Calbiochem; DAF-2 DA: 5 μM, 60 min at room temperature). The NO-insensitive dye DAF-4 (5 μM) was used as a negative control for NO detection. Cells were imaged as previously described (Meuchel et al., 2011 ) using a real-time fluorescence imaging system (MetaFluor; Universal Imaging, 
Real-time simultaneous NO and Ca 2+ imaging
BECs grown in 8-well Labtek chambers were loaded with DAF-2 DA as well as the fluorescent calcium indicator X-Rhod-1 AM (Invitrogen: 1μM, 45 minutes at room temperature). Each dye was sequentially visualized using appropriate excitation/emission filter sets in the imaging system as above (quality control experiments done to verify absence of bleed through between the fluorescence channels). Calcium calibration was performed using X-Rhod-1 tripotassium salt (#84049 Anaspec, Fremont, CA) according to calcium calibration kit protocol (Invitrogen)
Force Measurements
Bronchial samples for force studies were collected from 3 rd to 6 th generation bronchi of female patients (as above). The connective tissue was removed by microdissection, and the bronchial epithelium was either retained (epithelium-intact) or mechanically removed (epithelium-denuded) by abrasion within the bronchial lumen via a fine wire brush. The bronchial rings (epithelium -intact or -denuded) were then suspended in a 5 ml organ bath (Radnotti Systems) and force measurements performed using calibrated force transducers (Grass Instruments FT03). Rings were maintained at 
RESULTS
ER Expression in Human BECs
Western analysis of cell fractions from unstimulated BECs revealed that both ERα and ERβ were expressed in the cytosol as well as plasma membrane (Figure 1), with a relatively higher membrane expression of ERα compared to ERβ. Nuclear expression of ERα or ERβ was small. Two-color fluorescent immunostaining confirmed the colocalization of both ERs with eNOS within the plasma membrane ( Figure 1C ). However, it should be noted that ERβ was also observed separate from eNOS, suggesting a non-caveolar expression of this isoform.
Sensitivity and Specificity of DAF-2 in BECs
The NO sensitive dye DAF-2 DA is intracellularly metabolized and converted to DAF-2, which fluoresces in proportion to the total NO that the dye binds over time (i.e. a cumulative response). To establish sensitivity and specificity of DAF-2 in isolated BECs for NO, a variety of NO and nitrous oxide (N 2 O) donors were used.
The fast-acting NO donor MAHMA-NONOate was perfused and exhibited a rapid increase in intracellular fluorescence that plateaued in approximately 3 min ( Figure   2A ). Sensitivity of DAF-2 for NO within BECs per se was determined as described recently for pulmonary artery endothelial cells (Meuchel et al., 2011) by constructing an empirical curve of amplitudes of fluorescence changes (difference from baseline at 15 min) using a range of MAHMA-NONOate concentrations (1nM to 10 μM).
Concentrations of 1 nM MAHMA-NONOate showed minimal changes over baseline fluorescent levels and were comparable to vehicle controls. Maximal fluorescence as This article has not been copyedited and formatted. The final version may differ from this version. Figure 2B ). The empirical calibration was used to determine the rate of NO production in subsequent protocols.
We verified that the rate of change in DAF-2 fluorescence reflected NO release or production. At similar concentrations, the NO donor DEA-NONOate (DEANO) showed a slower rate of increase ( Figure 2D ) and reached a smaller amplitude ( Figure 2C 
ER activation induces NO production in BECs
Exposure of BECs to E 2 (10 nM; ERα and ERβ activation), THC (10 nM; ERα activation) or DPN (10 nM; ERβ activation) all increased DAF-2 fluorescence ( Figure 4A) such that by 15 min, these ER agonists had produced significant increases in NO, There is recent evidence in non-airway tissues for involvement of a G-protein coupled receptor (GPCR30 or GPER) in non-genomic estrogen signaling (Langer et al.) .
Whether GPCR30 is present and functional in BECs is not known. However, the GPCR30 specific agonist G-1 (50 μM) had no effect on NO levels (Figure 4) . Additionally, Western analysis of BECs for GPCR30 showed no detectable expression of this receptor (data not shown). Accordingly, this avenue of estrogen signaling was not explored further.
A concentration-response for E 2 induced-NO production (10 pM to 100 nM E 2 ) revealed minimal NO production at 10 pM E 2 , and maximal response at 10 nM ( Figure 5 ).
Qualitatively similar results were obtained for ER-specific agonists THC (ERα) and DPN (ERβ) (Figure 6 ). Both of these ER isoform-specific agonists showed minimal NO production at 10 pM. DPN-induced NO response saturated at 10 nM, while THC-induced response was maximal at 100 nM. Maximal amplitudes were taken at 15 min and the curve was fitted with a 4-parameter sigmoid (R 2 = 0.993; E2, R 2 =0.992; THC, R 2 =0.996; DPN).
Mechanisms of E 2 -induced NO production in BECs
Pre-treatment of BECs with the non-specific ER antagonist ICI 182,780 (ICI: 1 μM, 30 min) completely abrogated subsequent E 2 -induced increase in NO (Figure 7 ; p<0.05). Previous studies have already established the association between caveolae and eNOS (Garcia-Cardena et al., 1997; Ju et al., 1997) , and the importance of Ca
2+
-induced dissociation of eNOS in subsequent NO production (Kone, 2000) . Human bronchial epithelium is known to express the constitutive caveolar protein caveolin-1 (Krasteva et al., 2006) . Pre-treatment of BECs with the caveolin-1 scaffolding domain peptide (CSD: 5 μM, 4 hour pre-treatment), which inhibits caveolin-1 function, significantly attenuated both THC-and DPN-induced NO production by ~50% (p<0.05; Figure 9 ).
Effect of E 2 on Akt and eNOS phosphorylation
Phosphorylation of Akt and eNOS are known to be key steps in the production of NO (Hurt et al., 2002) . In airway epithelium this pathway is initiated by many agonists 
E 2 effects on bronchodilation
In epithelium-intact human bronchial rings from female patients, exposure to 1 μM ACh produced a typical, sustained force response (Figure 11 ). Exposure to 10 nM E 2 THC or DPN each produced rapid relaxation within a 15 min time frame that was comparable between treatments ( Figure 11 ). It should be noted that a 15 min time period was selected to match the NO imaging data. However, longer exposure to ER agonists resulted in >50% relaxation (not shown). Denudation of epithelium blunted E 2 effects on bronchodilation ( Figure 11 shows E 2 , but a similar lack of effect was observed for THC and DPN).
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DISCUSSION
In this study, biologically relevant concentrations of estrogen as well as ERspecific agonists induced physiologically significant levels of NO in human BECs and produced bronchodilation via an epithelium-dependent mechanism. Estrogen acts on the bronchial epithelium via both major ER isoforms which are expressed in the membrane and cytosol, and induce NO within a matter of minutes. These data point to non-genomic mechanisms (involving Akt and eNOS phosphorylation), providing novel evidence for a functional role of non-nuclear ERs in the airway epithelium. Combined with our previous study in human ASM cells (Townsend et al., 2010) , the novel findings of E 2 -induced NO production suggest an important bronchodilatory role for sex steroids. The relevance of such effects lies in the normal effects of estrogens on the airway, and the dysregulation of estrogen signaling in the setting of diseases such as asthma which involves impaired NOmediated bronchodilation and enhanced ASM contractility.
Estrogen signaling involves the potent ER agonist 17β-estradiol (E 2 ). While airway ER expression, especially in humans, has not been well-studied, based on perimenstrual fluctuations in asthma symptoms, ER expression is likely. One previous study reported ERα and ERβ expression in human BECs (Ivanova et al., 2009 ), but examined only genomic actions of ER activation in these cells. Genomic responses to estrogens are known to be complex, cell-specific, estrogen concentration and duration dependent, and involve a host of signaling proteins and pathways (Heldring et al., 2007) . Given these complexities, and the relative lack of knowledge on estrogen signaling within the airway epithelium, we did not address the issue of prolonged estrogen exposure in BECs in this study, while recognizing its importance in vivo. In this regard, the results of our present While rapid and likely non-genomic effects of E 2 occurring within seconds to minutes have been observed in other tissues (Levin, 2002; Simoncini and Genazzani, 2003) , the underlying mechanisms are still under investigation. Previous work, but not in the lung, has focused on non-genomic actions of ERα and ERβ (Levin, 2002; Heldring et al., 2007) . The presence of both ER isoforms in the BEC plasma membrane, and the current results on NO production and bronchodilation using ER isoform specific agonists (THC vs. DPN) suggest that both ERα and ERβ are functional in terms of non-genomic regulation of NO in airway epithelium. Blocking ER activation with the ER antagonist ICI 182,780 attenuated NO production in BECs further confirming that rapid, nongenomic ERα or ERβ activation was responsible for the observed NO effects. In other tissues, there is recent evidence for a G-protein coupled receptor (GPCR30 or GPER) in non-genomic estrogen signaling (Langer et al., 2010) . This receptor is not blocked by ICI 182,780. To date, we have not detected GPCR30 in human airway, and the GPCR30 agonist G-1 had no effect on BEC-induced NO production, suggesting that this receptor is not a key player in estrogen-induced NO effects in the airway.
While the present study has demonstrated that BECs have ERs, there is currently limited data on estrogen signaling per se within the airway epithelium. A previous study using H441 epithelial cells found that acute exposure to E 2 increases conversion of [3H] Larginine to [3H] L-citrulline (Kirsch et al., 1999) , although NO production was not measured. We now show that estradiol rapidly increases NO production in acutely This article has not been copyedited and formatted. The final version may differ from this version. Only a single report in airway epithelium (Kirsch et al., 1999) This is in contrast to previous work (Kirsch et al., 1999) showing a role for influx. (Boitano et al., 1992) . However, this is the first evidence for estrogen effects on BEC NO via mobilization of intracellular Ca 2+ stores.
Caveolin-1 is an important regulator of membrane localization of eNOS with dissociation of eNOS from caveolae being an important step in NO production (Kone, 2000) . Accordingly, interactions of caveolin-1 scaffolding domain with eNOS inhibits NO production (Ju et al., 1997) ] i (Townsend et al., 2010) , estrogens may counteract the bronchoconstricting action of ACh on ASM itself, albeit less effectively than if the epithelium was present. This latter aspect may be particularly important in the role of estrogens in determining the balance between bronchoconstriction and bronchodilation in the setting of dysfunctional epithelium in airway diseases.
The clinical relevance of our study lies in diseases such as asthma which are more prevalent in women (Melgert et al., 2007; Postma, 2007) , with increased severity and frequency of exacerbations (Becklake and Kauffmann, 1999) , and catamenial variations in airway reactivity in ~40% of women with pre-existing disease (Chhabra, 2005; Murphy and Gibson, 2008) . Clinical data suggest that estrogens are detrimental in asthma; however, asthma exacerbations are greater during late luteal phase when estrogen levels are lowest (Hanley, 1981; Gibbs et al., 1984) , and can be alleviated in postmenopausal women receiving hormone replacement therapy (Bellia and Augugliaro, 2007) . We and others have shown that estrogen can exhibit relaxant effects directly on the ASM, in part by decreasing [Ca 2+ ] i via L-type (Townsend et al., 2010) and BK Ca channels (Dimitropoulou et al., 2005) (the latter being responsive to cGMP, a downstream effector of NO). Indeed, it is likely that estrogen-induced epithelial NO stimulates guanylyl cyclase in the underlying ASM, producing bronchodilation in humans similar to murine models (Dimitropoulou et al., 2005) . Our study suggests that the epithelial-derived NO may stimulate guanylyl cyclase in ASM. Thus, estrogens may have a two-pronged effect in inducing bronchodilation.
A potential confounding factor in examining the role of estrogens is the role of airway inflammation, and how estrogens interact with inflammatory mediators in modulating airway tone. Here, inflammation-induced alterations in NO (e.g. due to enhanced epithelial iNOS (Ortiz and Garvin, 2003; Jiang et al., 2009 )) may also be relevant. Asthma severity correlates with increasing levels of exhaled NO, a marker of airway inflammation. Menstrual variations in exhaled NO have been reported (Mandhane et al., 2009 ) which suggest regulation of NO by sex steroids; however the underlying mechanisms remain unknown. It must be noted that in our study, we examined only normal BECs not exposed to inflammatory mediators. Accordingly, we found very low levels of iNOS, and as expected, iNOS inhibition did not alter NO production by E 2 , This article has not been copyedited and formatted. The final version may differ from this version. 34 E 2 on NO production. In contrast, the iNOS inhibitor 1400W (10μM; 30 min), did not alter the amount of NO produced by E 2 (or that by THC or DPN; not shown).
In bar graphs (B), values are means + SE (n=5 patients). * indicates significant difference from vehicle control, # significant inhibitor effect (p<0.05). 
